CNBC
@CNBC
First in business worldwide.
加入 February 2009
820 正在关注 6.2M 粉丝
Novartis shares tanked 10% on Tuesday after the pharmaceutical giant said its del-desiran drug for muscle-wasting disorder failed in a late-stage trial, its third drug trial setback in a week.
Check out CNBC's analysis of this breaking story:
显示更多
